In Vitro Modeling of Mycelium Biomass Growth Kinetics of the Novel Fungicolous Species Xylaria karsticola NBIMCC 9097, with Insights into Its Antimicrobial Potential
Abstract
1. Introduction
2. Materials and Methods
2.1. Fungal Strain
2.2. In Vitro Cultivation Procedures
2.2.1. Screening of Carbon Sources
2.2.2. Screening of Nutrient Media and Composition Optimization
2.2.3. Modeling of the Mycelium Growth Kinetics
2.3. Assessment of the Antibacterial Potential
2.3.1. Submerged Cultivation of X. karsticola in the Optimized Medium
2.3.2. Preparation of Extracts from Mycelial Biomass and Cultural Liquid
2.3.3. Determination of the Antimicrobial Activity of the X. karsticola Extracts
2.4. Statistical Analysis
3. Results and Discussion
3.1. Screening of Carbon Sources
3.2. Screening of Nutrient Media and Composition Optimization
3.3. Modeling of the Mycelium Growth Kinetics
3.4. Assessment of the Antibacterial Potential
4. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
Abbreviations
| NBIMCC | National Bank of Industrial Microorganisms and Cell Cultures |
| MCM | Mushroom Complete Medium |
| MEB | Malt extract broth |
| MYB | Malt extract yeast extract broth |
| PDB | Potato dextrose broth |
| CDB | Czapek–Dox Broth |
| CCD | Central Composite Design |
| PTFE | Polytetrafluoroethylene |
| ATCC | The American Type Culture Collection |
| CFU | Colony-Forming Unit |
| CLSI | Clinical and Laboratory Standards Institute |
| SD | Standard deviation |
| Glu | Glucose |
| YE | Yeast extract |
| P | Peptone |
| MIC | Minimal inhibitory concentration |
| BWE | Biomass Water Extract |
| BME | Biomass Methanol Extract |
| BEE | Biomass Ethanol Extract |
| BBE | Biomass Buthanol Extract |
| BHE | Biomass Hexane Extract |
| BEAE | Biomass Ethyl Acetate Extract |
| BMCE | Biomass Methylene Chloride Extract |
| CLMCE | Cultural Liquid Methylene Chloride Extract |
| CLBE | Cultural Liquid Buthanol Extract |
| CLHE | Cultural Liquid Hexane Extract |
| CLEAE | Cultural Liquid Ethyl Acetate Extract |
References
- Dzobo, K. The role of natural products as sources of therapeutic agents for innovative drug discovery. Compr. Pharmacol. 2022, 408–422. [Google Scholar] [CrossRef]
- Aware, C.B.; Patil, D.N.; Suryawanshi, S.S.; Mali, P.R.; Rane, M.R.; Gurav, R.G.; Jadhav, J.P. Natural bioactive products as promising therapeutics: A review of natural product-based drug development. S. Afr. J. Bot. 2022, 151, 512–528. [Google Scholar] [CrossRef]
- Lee, S.-H. Therapeutic effects of natural products on human diseases. Life 2024, 14, 1166. [Google Scholar] [CrossRef]
- Atanasov, A.G.; Zotchev, S.B.; Dirsch, V.M.; Supuran, C.T. Natural products in drug discovery: Advances and opportunities. Nat. Rev. Drug Discov. 2021, 20, 200–216. [Google Scholar] [CrossRef]
- Nwobodo, D.C.; Ugwu, M.C.; Anie, C.O.; Al-Ouqaili, M.T.S.; Ikem, J.C.; Chigozie, V.U.; Saki, M. Antibiotic resistance: The challenges and some emerging strategies for tackling a global menace. J. Clin. Lab. Anal. 2022, 36, e24655. [Google Scholar] [CrossRef]
- Salam, M.A.; Al-Amin, M.Y.; Salam, M.T.; Pawar, J.S.; Akhter, N.; Rabaan, A.A.; Alqumber, M.A.A. Antimicrobial resistance: A growing serious threat for global public health. Healthcare 2023, 11, 1946. [Google Scholar] [CrossRef] [PubMed]
- Ahmed, S.K.; Hussein, S.; Qurbani, K.; Ibrahim, R.H.; Fareeq, A.; Mahmood, K.A.; Mohamed, M.G. Antimicrobial resistance: Impacts, challenges, and future prospects. J. Med. Surg. Public Health 2024, 2, 100081. [Google Scholar] [CrossRef]
- Schrey, H.; Lambert, C.; Stadler, M. Fungi: Pioneers of chemical creativity—Techniques and strategies to uncover fungal chemistry. IMA Fungus 2025, 16, e142462. [Google Scholar] [CrossRef] [PubMed]
- Dai, G.; Shen, Q.; Zhang, Y.; Bian, X. Biosynthesis of fungal natural products involving two separate pathway crosstalk. J. Fungi 2022, 8, 320. [Google Scholar] [CrossRef] [PubMed]
- Meshram, P.A.; Nischitha, R. Harnessing the bioactive potential of endophytic Xylaria species: A comprehensive review on natural drug discovery and biotechnological applications. Physiol. Mol. Plant Pathol. 2025, 140, 102963. [Google Scholar] [CrossRef]
- Paterson, R.R.M.; Solaiman, Z.; Santamaria, O. Guest edited collection: Fungal evolution and diversity. Sci. Rep. 2023, 13, 21438. [Google Scholar] [CrossRef]
- Wall, G.; Lopez-Ribot, J.L. Current antimycotics, new prospects, and future approaches to antifungal therapy. Antibiotics 2020, 9, 445. [Google Scholar] [CrossRef]
- Karwehl, S.; Stadler, M. Exploitation of fungal biodiversity for discovery of novel antibiotics. Curr. Top. Microbiol. Immunol. 2017, 398, 303–338. [Google Scholar] [CrossRef]
- Niño-Vega, G.A.; Padró-Villegas, L.; López-Romero, E. New ground in antifungal discovery and therapy for invasive fungal infections: Innovations, challenges, and future directions. J. Fungi 2024, 10, 871. [Google Scholar] [CrossRef] [PubMed]
- Spiteller, P. Chemical defence strategies of higher fungi. Chem. Eur. J. 2008, 14, 9100–9110. [Google Scholar] [CrossRef]
- Bills, G.F.; Gloer, J.B. Biologically active secondary metabolites from the fungi. Microbiol. Spectr. 2016, 4, FUNK-0009-2016. [Google Scholar] [CrossRef] [PubMed]
- Sun, J.-Z.; Liu, X.-Z.; McKenzie, E.H.C.; Jeewon, R.; Li, Y.-L.; Lin, C.-G.; Tian, Q. Fungicolous fungi: Terminology, diversity, distribution, evolution, and species checklist. Fungal Divers. 2019, 95, 337–430. [Google Scholar] [CrossRef]
- Maurice, S.; Arnault, G.; Nordén, J.; Botnen, S.S.; Miettinen, O.; Kauserud, H. Fungal sporocarps house diverse and host-specific communities of fungicolous fungi. ISME J. 2021, 15, 1445–1457. [Google Scholar] [CrossRef] [PubMed]
- Pan, R.; Bai, X.; Chen, J.; Zhang, H.; Wang, H. Exploring structural diversity of microbe secondary metabolites using the OSMAC strategy: A literature review. Front. Microbiol. 2019, 10, 294. [Google Scholar] [CrossRef]
- Shin, H.-J.; Ro, H.-S.; Kawauchi, M.; Honda, Y. Review on mushroom mycelium-based products and their production process: From upstream to downstream. Bioresour. Bioprocess. 2025, 12, 3. [Google Scholar] [CrossRef]
- Rämä, T.; Quandt, C.A. Improving fungal cultivability for natural products discovery. Front. Microbiol. 2021, 12, 706044. [Google Scholar] [CrossRef] [PubMed]
- Bakratsas, G.; Polydera, A.; Katapodis, P.; Stamatis, H. Recent trends in submerged cultivation of mushrooms and their application as a source of nutraceuticals and food additives. Future Foods 2021, 4, 100086. [Google Scholar] [CrossRef]
- Krupodorova, T.; Barshteyn, V.; Sekan, A. Review of the basic cultivation conditions influence on the growth of basidiomycetes. Curr. Res. Environ. Appl. Mycol. 2021, 11, 494–531. [Google Scholar] [CrossRef]
- Tang, Y.-J.; Zhu, L.-W.; Li, H.-M.; Li, D.-S. Submerged culture of mushrooms in bioreactors—Challenges, current state-of-the-art, and future prospects. Food Technol. Biotechnol. 2007, 45, 221–229. [Google Scholar]
- Röhrich, C.R.; Iversen, A.; Jaklitsch, W.M.; Voglmayr, H.; Vilcinskas, A.; Nielsen, K.F.; Thrane, U.; von Döhren, H.; Brückner, H.; Degenkolb, T. Screening the biosphere: The fungicolous fungus Trichoderma phellinicola, a prolific source of hypophellins, new 17-, 18-, 19-, and 20-residue peptaibiotics. Chem. Biodivers. 2013, 10, 787–812. [Google Scholar] [CrossRef]
- Kaur, A.; Rogers, K.D.; Swenson, D.E.; Dowd, P.F.; Wicklow, D.T.; Gloer, J.B. Bioactive natural products from fungicolous Hawaiian isolates: Secondary metabolites from a Phialemoniopsis sp. Mycology 2014, 3, 120–129. [Google Scholar] [CrossRef][Green Version]
- Rogers, J.; Ju, Y.-M. The Xylariaceae of the Hawaiian Islands. N. Am. Fungi 2012, 7, 1–35. [Google Scholar] [CrossRef]
- Fournier, J.; Flessa, F.; Persoh, D.; Stadler, M. Three new Xylaria species from southwestern Europe. Mycol. Prog. 2011, 10, 33–52. [Google Scholar] [CrossRef]
- Fournier, J. Update on European Species of Xylaria. Available online: http://www.ascofrance.fr/uploads/xylaria/201406.pdf (accessed on 10 January 2026).
- Cañón, E.R.P.; de Albuquerque, M.P.; Alves, R.P.; Pereira, A.B.; Victoria, F.d.C. Morphological and molecular characterization of three endolichenic isolates of Xylaria. Plants 2019, 8, 399. [Google Scholar] [CrossRef] [PubMed]
- Angelova, G.; Stefanova, P.; Brazkova, M.; Krastanov, A. Molecular and morphological characterization of Xylaria karsticola. PLoS ONE 2023, 18, e0287679. [Google Scholar] [CrossRef]
- Zhao, Z.-Z.; Wang, Y.; Wang, X.-Y.; Chen, H.; Wang, Z.-Z.; Wang, J.-K.; Wang, L.-L.; Shen, M.-J.; Pang, X.; Feng, W.-S. Diverse metabolites with anti-psoriasis potential from different fermentations of the fungicolous fungus Xylarialongipes HFG1018. IMA Fungus 2025, 16, e153522. [Google Scholar] [CrossRef] [PubMed]
- Elhamouly, N.A.; Hewedy, O.A.; Zaitoon, A.; Miraples, A.; Elshorbagy, O.T.; Hussien, S.; El-Tahan, A.; Peng, D. The hidden power of secondary metabolites in plant–fungi interactions and sustainable phytoremediation. Front. Plant Sci. 2022, 13, 1044896. [Google Scholar] [CrossRef]
- Sun, J.-Z.; Liu, X.-Z.; Jeewon, R.; Li, Y.-L.; Lin, C.-G.; Tian, Q.; Zhao, Q.; Xiao, X.-P.; Hyde, K.-D.; Nilthong, S. Fifteen fungicolous ascomycetes on edible and medicinal mushrooms in China and Thailand. Asian J. Mycol. 2019, 2, 129–169. [Google Scholar] [CrossRef]
- Liu, D.; He, X.; Chater, C.; Perez-Moreno, J.; Yu, F. Microbiome community structure and Functional Gene Partitioning in different micro-niches within a sporocarp-forming fungus. Front. Microbiol. 2021, 12, 629352. [Google Scholar] [CrossRef]
- Deshmukh, S.K.; Sridhar, K.R.; Saxena, S.; Gupta, M.K. Recent advances in the discovery of bioactive metabolites from Xylaria. In Biology, Cultivation and Applications of Mushrooms; Arya, A., Rusevska, K., Eds.; Springer: Singapore, 2022; pp. 59–92. [Google Scholar] [CrossRef]
- Becker, K.; Stadler, M. Recent progress in biodiversity research on the Xylariales and their secondary metabolism. J. Antibiot. 2021, 74, 1–23. [Google Scholar] [CrossRef]
- Pham, N.S.; Le, T.T.X.; Pham, Q.A.; Vu, T.H.N.; Quach, N.T.; Nguyen, T.T.L.; Do, T.T.; Do, H.A.; Tran, H.Q.; Chu, K.-S.; et al. The Cytotoxicity and Antioxidant Potentials of the Endophytic Fungus Xylaria sp. KET18 Associated with Keteleeria evelyniana Mast. Appl. Sci. 2024, 14, 11070. [Google Scholar] [CrossRef]
- Rakshith, D.; Gurudatt, D.M.; Rao, H.Y.; Mohana, N.C.; Nuthan, B.R.; Ramesha, K.P.; Satish, S. Bioactivity-Guided Isolation of Antimicrobial Metabolite from Xylaria sp. Process Biochem. 2020, 92, 378–385. [Google Scholar] [CrossRef]
- Chen, W.; Yu, M.; Chen, S.; Gong, T.; Xie, L.; Liu, J.; Bian, C.; Huang, G.; Zheng, C. Structures and Biological Activities of Secondary Metabolites from Xylaria spp. J. Fungi 2024, 10, 190. [Google Scholar] [CrossRef]
- Chapla, V.M.; Zeraik, M.L.; Cafeu, M.C.; Silva, G.H.; Cavalheiro, A.J.; Bolzani, V.S.; Young, M.C.M.; Pfenning, L.H.; Araujo, A.R. Griseofulvin, Diketopiperazines and Cytochalasins from Endophytic Fungi Colletotrichum crassipes and Xylaria sp., and Their Antifungal, Antioxidant and Anticholinesterase Activities. J. Braz. Chem. Soc. 2018, 29, 1707–1713. [Google Scholar] [CrossRef]
- Chen, H.P.; Li, J.; Zhao, Z.Z.; Li, X.; Liu, S.-L.; Wang, Q.-Y.; Liu, J.-K. Diterpenes with Bicyclo[2.2.2]octane Moieties from the Fungicolous Fungus Xylaria longipes HFG1018. Org. Biomol. Chem. 2020, 18, 2410–2415. [Google Scholar] [CrossRef]
- Chen, H.P.; Zhao, Z.Z.; Cheng, G.G.; Zhao, K.; Han, K.-Y.; Zhou, L.; Feng, T.; Li, Z.-H.; Liu, J.-K. Immunosuppressive Nor-Isopimarane Diterpenes from Cultures of the Fungicolous Fungus Xylaria longipes HFG1018. J. Nat. Prod. 2020, 83, 401–412. [Google Scholar] [CrossRef]
- Li, J.; Tan, Y.-F.; Zhou, S.-Q.; Liu, S.; Wang, W.-X.; Jiang, Y.-P.; Long, H.-P.; Liu, J.-K. Neuroprotective Methylsuccinic Acid and Enoic Acid Derivatives from the Fungus Xylaria longipes. Phytochemistry 2023, 210, 113652. [Google Scholar] [CrossRef]
- Macías-Rubalcava, M.L.; Sánchez-Fernández, R.E. Secondary Metabolites of Endophytic Xylaria Species with Potential Applications in Medicine and Agriculture. World J. Microbiol. Biotechnol. 2017, 33, 15. [Google Scholar] [CrossRef]
- Wei, S.-S.; Lai, J.-Y.; Chen, C.; Zhang, Y.-J.; Nong, X.-M.; Qiu, K.-D.; Duan, F.-F.; Zou, Z.-X.; Tan, H.-B. Sesquiterpenes and α-Pyrones from an Endophytic Fungus Xylaria curta YSJ-5. Phytochemistry 2024, 220, 114011. [Google Scholar] [CrossRef]
- Liang, A.-L.; Tan, Y.-F.; Lu, W.-Y.; Xu, P.-J.; Yuan, Y.-Y.; Chen, Q.-A.; Long, H.-P.; Wang, W.-X.; Li, J. A Comprehensive Review of the Metabolites, Biological Activities, and Clinical Application of a Medicinal Fungus Xylaria nigripes. J. Ethnopharmacol. 2025, 350, 120041. [Google Scholar] [CrossRef] [PubMed]
- Jang, Y.W.; Lee, I.K.; Kim, Y.S.; Seok, S.J.; Yu, S.H.; Yun, B.S. Chemical Constituents of the Fruiting Body of Xylaria polymorpha. Mycobiology 2009, 37, 207–210. [Google Scholar] [CrossRef]
- Atamanchuk, A.R.; Bisko, N.A. Isolation and Characterisation of Melanin Pigment from Mycelial Cultures of Xylaria polymorpha (Ascomycota). Ukr. Bot. J. 2024, 81, 8–15. [Google Scholar] [CrossRef]
- Bouguettoucha, A.; Balannec, B.; Amrane, A. Unstructured Models for Lactic Acid Fermentation—A Review. Food Technol. Biotechnol. 2011, 49, 3–12. [Google Scholar]
- Ibarz, A.; Augusto, P.E. An Autocatalytic Kinetic Model for Describing Microbial Growth during Fermentation. Bioprocess Biosyst. Eng. 2015, 38, 199–205. [Google Scholar] [CrossRef]
- Gaponov, K.P. Processes and Apparatus for Microbiological Industry; Legkaya i Pishchevaya Promyshlennost: Moscow, Russia, 1981; p. 240. (In Russian) [Google Scholar]
- Stefanova, P.; Georgieva, A.; Brazkova, M.; Baldzhieva, R.; Goranov, B.; Blazheva, D.; Slavov, A.; Angelova, G. Molecular Identification, Mycelial Growth Kinetics, and Antimicrobial Potential of Newly Isolated Medicinal Mushroom Fomitopsis pinicola from Bulgaria. J. Fungi 2025, 11, 727. [Google Scholar] [CrossRef] [PubMed]
- Clinical and Laboratory Standards Institute (CLSI). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically: Approved Standard, 9th ed.; CLSI Document M07-A9; CLSI: Wayne, PA, USA, 2012. [Google Scholar]
- Clinical and Laboratory Standards Institute (CLSI). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts, 4th ed.; CLSI Document M27-A3; CLSI: Wayne, PA, USA, 2017. [Google Scholar]
- Liu, X.; Gao, C.; Zhong, Y.T.; Yuan, X.H.; He, X.S.; Ma, L. Optimization of Submerged Culture Conditions for Xylaria striata Mycelium. Zhong Yao Cai 2014, 37, 1317–1321. [Google Scholar] [PubMed]
- Lopez, M.K.S.; Kalaw, S.P.; Dulay, R.M.R.; De Leon, A.M.; Reyes, R.G. Optimization of Mycelial Growth of Xylaria papulis Lloyd (Xylariaceae) in Indigenous Liquid Culture Conditions, Science City of Muñoz, Nueva Ecija, Philippines. Stud. Fungi 2022, 7, 21. [Google Scholar] [CrossRef]
- Jayasekara, L.A.C.B.; Poonsawad, A.; Watchaputi, K.; Wattanachaisaereekul, S.; Soontorngun, N. Media Optimization of Antimicrobial Activity Production and Beta-Glucan Content of Endophytic Fungus Xylaria sp. BCC 1067. Biotechnol. Rep. 2022, 35, e00742. [Google Scholar] [CrossRef]
- Zhang, Y.; Cai, J.; Huang, L.; Xu, Z.; Yang, X.; Li, J.; Zhu, X. Improving the Productivity of 19,20-Epoxy-Cytochalasin Q in Xylaria sp. sof11 with Culture Condition Optimization. Prep. Biochem. Biotechnol. 2016, 46, 461–466. [Google Scholar] [CrossRef]
- Zeng, X.; Wang, H.; He, L.; Lin, Y.; Li, Z. Medium Optimization of Carbon and Nitrogen Sources for the Production of Eucalyptene A and Xyloketal A from Xylaria sp. 2508 Using Response Surface Methodology. Process Biochem. 2006, 41, 293–298. [Google Scholar] [CrossRef]
- Panjaitan, D.; Fastanti, F.S.; Naibaho, F.G. Antimicrobial and Antioxidant Activities of Some Xylariaceous Fungi. Biotropika J. Trop. Biol. 2025, 13, 149–157. [Google Scholar] [CrossRef]
- Yadav, G.; Sonigra, P.; Nagda, A.; Mehta, T.; Sahoo, A.; Meena, M.; Swapnil, P. Phytochemical and Bioactive Insights into Endophytic Fungi from Wrightia tinctoria with Emphasis on Xylaria rohrensis Metabolites Potential. Sci. Rep. 2026, 16, 475. [Google Scholar] [CrossRef]
- Ramesh, V.; Arivudainambi, U.E.; Thalavaipandian, A.; Karunakaran, C.; Rajendran, A. Antibacterial Activity of Wild Xylaria sp. Strain R005 (Ascomycetes) against Multidrug-Resistant Staphylococcus aureus and Pseudomonas aeruginosa. Int. J. Med. Mushrooms 2012, 14, 47–53. [Google Scholar] [CrossRef] [PubMed]
- Yong, D.L.; López, O.G.; Castro, A.S.; Romero, E.S.M.; Palma, J.J.Z.; Rodríguez, J.R. Antibacterial Activity and Virulence Factors Inhibition by Xylaria sp. (Xylariaceae, Ascomycota): A Study of Bioactive Potential. Trop. Subtrop. Agroecosyst. 2023, 26, 116. [Google Scholar] [CrossRef]
- Rajendran, S.; Robertson, L.P.; Kosgahakumbura, L.; Fernando, C.; Göransson, U.; Wang, H.; Hettiarachchi, C.; Gunasekera, S. Antibacterial Eremophilane Sesquiterpenoids from Xylaria feejeensis, an Endophytic Fungus of the Medicinal Plant Geophila repens. Fitoterapia 2023, 167, 105496. [Google Scholar] [CrossRef] [PubMed]
- Santiago, K.A.A.; Edrada-Ebel, R.; Dela Cruz, T.E.E.; Cheow, Y.L.; Ting, A.S.Y. Biodiscovery of Potential Antibacterial Diagnostic Metabolites from the Endolichenic Fungus Xylaria venustula Using LC–MS-Based Metabolomics. Biology 2021, 10, 191. [Google Scholar] [CrossRef]
- Ramesh, V.; Karunakaran, C.; Rajendran, A. Evaluation of Synergistic and Antibacterial Activity of Xylaria curta against Drug-Resistant Staphylococcus aureus and Pseudomonas aeruginosa. Mycology 2012, 3, 252–257. [Google Scholar] [CrossRef]
- Canli, K.; Akata, I.; Altuner, E.M. In Vitro Antimicrobial Activity Screening of Xylaria hypoxylon. Afr. J. Tradit. Complement. Altern. Med. 2016, 13, 42–46. [Google Scholar] [CrossRef] [PubMed]







| MCM | MEB * | MYB * | PDB * | CDB * | |
|---|---|---|---|---|---|
| Glucose | 20.0 | - | 10 | 20.0 | - |
| Sucrose | - | - | - | - | 30.0 |
| Peptone | 2.0 | 3.0 | - | - | - |
| Yeast extract | 2.0 | - | 5.0 | - | - |
| Malt extract | - | 30.0 | 3.0 | - | - |
| Potato extract | - | - | - | 4.0 | - |
| NaNO3 | - | - | - | - | 2.0 |
| MgSO4·7H2O | 0.5 | - | - | - | 0.5 |
| K2HPO4 | 1.0 | - | - | - | 1.0 |
| KH2PO4 | 0.5 | - | - | - | - |
| KCl | - | - | - | - | 0.5 |
| FeSO4·7H2O | - | - | - | - | 0.01 |
| (A) | 24 h | 48 h | 72 h | 96 h | 120 h | 144 h | 168 h |
| Glucose | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
| Fructose | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
| Sucrose | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
| Maltose | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
| Rafinose | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
| (B) | 48 h | 72 h | 96 h | 144 h | 168 h | 192 h | 216 h |
| Arabinose | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
| Celobiose | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
| Cellulose | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
| MCM | MEB | MYB | PDB | CDB | |
|---|---|---|---|---|---|
| Biomass, g/dm3 | 9.9 ± 0.21 b | 8.8 ± 0.18 c | 10.8 ± 0.28 a | 7.8 ± 0.16 d | 6.0 ± 0.14 e |
| Component, g/dm3 | Lower Level | Basic Level | Higher Level | ||
|---|---|---|---|---|---|
| Glucose | 14.26 | 20 | 40 | 60 | 65.74 |
| Yeast extract | 0.93 | 1.5 | 3.5 | 5.5 | 6.07 |
| Peptone | 0.93 | 1.5 | 3.5 | 5.5 | 6.07 |
| Component, g/dm3 | Lower Level | Basic Level | Higher Level | ||
|---|---|---|---|---|---|
| Glucose | 2.82 | 10 | 35 | 60 | 67.18 |
| Yeast extract | 0.93 | 1.5 | 3.5 | 5.5 | 6.07 |
| Malt extract | 0.93 | 1.5 | 3.5 | 5.5 | 6.07 |
| Independent Variables | Response | ||
|---|---|---|---|
| Glucose, g/dm3 | Peptone, g/dm3 | Yeast extract, g/dm3 | Biomass, g/dm3 |
| 40.0 | 3.5 | 3.5 | 21.04 |
| 60.0 | 5.5 | 1.5 | 16.47 |
| 40.0 | 3.5 | 3.5 | 20.15 |
| 65.74 | 3.5 | 3.5 | 20.04 |
| 20.0 | 1.5 | 5.5 | 9.11 |
| 40.0 | 3.5 | 0.93 | 11.00 |
| 40.0 | 3.5 | 6.07 | 20.52 |
| 20.0 | 5.5 | 5.5 | 11.04 |
| 40.0 | 0.93 | 3.5 | 17.17 |
| 14.26 | 3.5 | 3.5 | 10.11 |
| 20.0 | 5.5 | 1.5 | 7.245 |
| 60.0 | 5.5 | 5.5 | 19.37 |
| 60.0 | 1.5 | 5.5 | 15.07 |
| 40.0 | 6.07 | 3.5 | 19.78 |
| 20.0 | 1.5 | 1.5 | 7.41 |
| 60.0 | 1.5 | 1.5 | 14.87 |
| Independent Variables | Responses | ||
|---|---|---|---|
| Glucose, g/dm3 | Peptone, g/dm3 | Yeast extract, g/dm3 | Biomass, g/dm3 |
| 10.0 | 5.5 | 1.5 | 6.06 |
| 60.0 | 5.5 | 1.5 | 17.23 |
| 2.82 | 3.5 | 3.5 | 4.530 |
| 35.0 | 6.07 | 3.5 | 11.33 |
| 10.0 | 5.5 | 5.5 | 7.41 |
| 35.0 | 3.5 | 0.93 | 3.70 |
| 35.0 | 3.5 | 6.07 | 14.68 |
| 67.18 | 3.5 | 3.5 | 22.44 |
| 10.0 | 1.5 | 5.5 | 6.70 |
| 60.0 | 1.5 | 1.5 | 12.06 |
| 10.0 | 1.5 | 1.5 | 5.48 |
| 35.0 | 3.5 | 3.5 | 12.18 |
| 35.0 | 3.5 | 3.5 | 12.2 |
| 60.0 | 1.5 | 5.5 | 22.84 |
| 35.0 | 0.93 | 3.5 | 10.91 |
| 60.0 | 5.5 | 5.5 | 22.10 |
| Independent Variable | Low, g/dm3 | High, g/dm3 | Optimum, g/dm3 |
|---|---|---|---|
| Glucose | 14.2562 | 65.7438 | 50.4581 |
| Peptone | 0.925623 | 6.07438 | 4.30301 |
| Yeast extracts | 0.925623 | 6.07438 | 4.30061 |
| Independent Variable | Low, g/dm3 | High, g/dm3 | Optimum, g/dm3 |
|---|---|---|---|
| Glucose | 2.82029 | 67.1797 | 67.1797 |
| Yeast extract | 0.925623 | 6.07438 | 1.24238 |
| Malt extract | 0.925623 | 6.07438 | 6.07438 |
| Medium | Logistic Curve Model | Reversible Autocatalytic Growth | |||||
|---|---|---|---|---|---|---|---|
| µmax, d−1 | β, g/dm3·d | R2 | k1, d−1 | , g/dm3 | K/1 + K | R2 | |
| MYB | 0.711 ± 0.003 b | 0.0311 ± 0.0002 b | 0.9946 | 0.0363 ± 0.0012 a | 23.05 ± 0.08 a | 0.9900 ± 0.001 a | 0.9913 |
| MCM | 0.803 ± 0.004 a | 0.0389 ± 0.0002 a | 0.9963 | 0.0359 ± 0.0004 a | 21.27 ± 0.04 b | 0.9644 ± 0.005 b | 0.9868 |
| Biomass Extracts | Culture Liquid Extracts | Controls (10 µg/disk) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BWE | BME | BEE | BBE | BHE | BEAE | BMCE | CLMCE | CLBE | CLHE | CLEAE | Gentamicin | Ketonazole | |
| Escherichia coli ATCC 8739 | - | - | - | - | - | - | 9.67 ± 0.58 | - | - | - | - | 10 ± 0.00 | - |
| Eterococcus faecalis ATCC 19433 | - | - | - | - | - | - | - | - | - | - | - | 15 ± 0.58 | - |
| Salmonella enterica ssp. enterica ser. Enetritidis ATCC 13076 | - | - | - | - | - | - | - | - | - | - | - | 16 ± 0.58 | - |
| Listeria monocytogenes ATCC 8787 | - | - | - | - | - | - | 8 ± 0.00 | 9 ± 0.58 | - | - | - | 23 ± 1.00 | - |
| Staphylococcus aureus ATCC 25923 | - | - | - | - | - | - | - | - | - | - | - | 13 ± 0.00 | - |
| Pseudomonas aeruginosa ATCC 9027 | - | 11 ± 1.00 | - | 15 ± 0.58 | 16 ± 1.00 | 20 ± 1.53 | 15 ± 0.58 | - | - | - | 8 ± 0.00 | 17 ± 0.58 | - |
| Proteus vulgaris G | - | - | - | - | - | - | - | - | - | - | - | 22 ± 0.58 | - |
| Klebsiella pneumoniae ATCC 13883 | - | - | - | - | - | - | - | - | - | - | - | 13 ± 1.00 | - |
| Candida albicans ATCC 10231 | - | - | - | - | - | 8 ± 0.00 | 8 ± 0.00 | 8 ± 0.00 | 9 ± 0.58 | - | - | - | 20 ± 0.58 |
| Bacillus subtilis ATCC 6633 | - | - | - | - | 8 ± 0.00 | 9 ± 0.58 | - | - | - | 20 ± 1.00 | - | ||
| Bacillus cereus ATCC 11778 | - | - | - | - | - | - | 9 ± 0.58 | 9 ± 1.00 | - | - | 11 ± 0.00 | 18 ± 1.00 | - |
| Wickerhamomyces anomalus | 8 ± 0.00 | - | 24 * ± 0.58 | - | - | - | - | - | 9 ± 1.00 | - | - | - | 28 ± 0.58 |
| Rhodotorula mucilaginosa | - | - | - | - | - | - | - | - | - | - | - | - | 34 ± 1.00 |
| Saccharomyces cerevisiae | - | - | - | - | - | - | - | - | - | - | - | - | 25 ± 0.58 |
| Saccharomycodes ludwigii | 10 ± 0.00 | - | - | - | - | 12 ± 1.00 | - | - | - | 12 ± 0.58 | - | - | 26 ± 1.00 |
| Pichia membranifaciens | 9 ± 0.58 | 10 ± 0.58 | - | - | - | - | - | - | - | - | - | - | 38 ± 1.00 |
| Test-Microorganism | Minimal Inhibitory Concentration, mg/cm3 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| BWE | BHE | BEAE | BMCE | CLBE | CLHE | CLEAE | Gentamicin | Ketonazole | |
| Escherichia coli ATCC 8739 | - | - | - | 2.12 | - | - | - | 0.02 | - |
| Pseudomonas aeruginosa ATCC 9027 | - | 0.067 | 0.59 | - | - | - | - | 0.0025 | - |
| Candida albicans ATCC 10231 | - | - | - | - | 3.22 | - | - | - | 0.00063 |
| Bacillus subtilis ATCC 6633 | - | - | 1.66 | - | - | - | - | 0.0025 | - |
| Bacillus cereus ATCC 11778 | - | - | - | - | - | - | 6.25 | 0.0012 | - |
| Wickerhamomyces anomalus | - | - | - | - | 1.61 | - | - | - | 0.005 |
| Saccharomycodes ludwigii | 0.02 | - | - | - | - | 0.04 | - | - | 0.02 |
| Pichia membranifaciens | 0.05 | - | - | - | - | - | - | - | 0.0012 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.
Share and Cite
Angelova, G.; Ganeva, Z.; Goranov, B.; Kaneva, N.; Brazkova, M.; Stefanova, P.; Blazheva, D. In Vitro Modeling of Mycelium Biomass Growth Kinetics of the Novel Fungicolous Species Xylaria karsticola NBIMCC 9097, with Insights into Its Antimicrobial Potential. J. Fungi 2026, 12, 177. https://doi.org/10.3390/jof12030177
Angelova G, Ganeva Z, Goranov B, Kaneva N, Brazkova M, Stefanova P, Blazheva D. In Vitro Modeling of Mycelium Biomass Growth Kinetics of the Novel Fungicolous Species Xylaria karsticola NBIMCC 9097, with Insights into Its Antimicrobial Potential. Journal of Fungi. 2026; 12(3):177. https://doi.org/10.3390/jof12030177
Chicago/Turabian StyleAngelova, Galena, Zlatka Ganeva, Bogdan Goranov, Nikoleta Kaneva, Mariya Brazkova, Petya Stefanova, and Denica Blazheva. 2026. "In Vitro Modeling of Mycelium Biomass Growth Kinetics of the Novel Fungicolous Species Xylaria karsticola NBIMCC 9097, with Insights into Its Antimicrobial Potential" Journal of Fungi 12, no. 3: 177. https://doi.org/10.3390/jof12030177
APA StyleAngelova, G., Ganeva, Z., Goranov, B., Kaneva, N., Brazkova, M., Stefanova, P., & Blazheva, D. (2026). In Vitro Modeling of Mycelium Biomass Growth Kinetics of the Novel Fungicolous Species Xylaria karsticola NBIMCC 9097, with Insights into Its Antimicrobial Potential. Journal of Fungi, 12(3), 177. https://doi.org/10.3390/jof12030177

























































